Drug research

setrusumab

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as BPS804; UX143

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Setrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaNCT06636071	RARE	Phase 3	Active not recruiting	2027-01Estimated
A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804NCT03118570	RARE	Phase 2	Completed	2019-10-01Actual

RAREActive not recruitingPrimary completion: 2027-01 · Estimated

Trial details

RARECompletedPrimary completion: 2019-10-01 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.